| abstract |
A compound of the general formula (I) shown herein (in the formula, the meaning of the variable is described herein) or a stereoisomer or mixture thereof, or a pharmaceutically acceptable salt. .. The pharmaceutical composition can contain a compound of the invention and can be used in a manner that inhibits the TLR7 / 8 receptor. The present invention further comprises a method of inhibiting the activity of TLR7, TLR8, or TLR7 / 8 in a subject, wherein the compounds of the general formulas (I) to (V) and the following formulas 1 to 30 or the pharmaceutical thereof are used. The present invention relates to a method comprising the step of administering an acceptable salt to a subject with the above-mentioned disability. |